Matches in Nanopublications for { ?s ?p "[Sorafenib and nilotinib resensitize tamoxifen resistant breast cancer cells to tamoxifen treatment via estrogen receptor ?.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Sorafenib and nilotinib resensitize tamoxifen resistant breast cancer cells to tamoxifen treatment via estrogen receptor ?.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Sorafenib and nilotinib resensitize tamoxifen resistant breast cancer cells to tamoxifen treatment via estrogen receptor ?.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1215604.RAFBioRgN7Es2e-nZGdM-Ob-Vo5Or9PgDm1iJrKQJsfcI130_assertion description "[Sorafenib and nilotinib resensitize tamoxifen resistant breast cancer cells to tamoxifen treatment via estrogen receptor ?.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215604.RAFBioRgN7Es2e-nZGdM-Ob-Vo5Or9PgDm1iJrKQJsfcI130_provenance.
- NP1215603.RAxt_IBcWrJTTzOMKLWXW744d-N6T464uXn9YiKkWEfGQ130_assertion description "[Sorafenib and nilotinib resensitize tamoxifen resistant breast cancer cells to tamoxifen treatment via estrogen receptor ?.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215603.RAxt_IBcWrJTTzOMKLWXW744d-N6T464uXn9YiKkWEfGQ130_provenance.